{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:05Z","timestamp":1791397325049,"version":"4.3.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000055","name":"NIDCD","doi-asserted-by":"publisher","award":["5R44DC008477"],"award-info":[{"award-number":["5R44DC008477"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pediatric Otorhinolaryngology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijporl.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T10:28:54Z","timestamp":1553077734000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants"],"prefix":"10.1016","volume":"121","author":[{"given":"Erik","family":"Pierstorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Wan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Jung Angel","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Kalinec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Slattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib1","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"issue":"25","key":"10.1016\/j.ijporl.2019.03.021_bib2","doi-asserted-by":"crossref","DOI":"10.1021\/cen-v083n025.p052","article-title":"Cisplatin","volume":"83","author":"Trzaska","year":"2005","journal-title":"Chem. Eng. News"},{"issue":"23","key":"10.1016\/j.ijporl.2019.03.021_bib3","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"8 Pt 1","key":"10.1016\/j.ijporl.2019.03.021_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1288\/00005537-198808000-00014","article-title":"Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing","volume":"98","author":"Kopelman","year":"1988","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.ijporl.2019.03.021_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced otoxocity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br. J. Canc."},{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib6","first-page":"584","article-title":"Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy","volume":"118","author":"Allen","year":"1998","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"16","key":"10.1016\/j.ijporl.2019.03.021_bib7","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"34","key":"10.1016\/j.ijporl.2019.03.021_bib8","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ijporl.2019.03.021_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijporl.2019.03.021_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlear indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ijporl.2019.03.021_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/MAO.0000000000001977","article-title":"A polymer-based extended release system for stable, long-term, intracochlear drug delivery","volume":"39","author":"Pierstorff","year":"2018","journal-title":"Otol. Neurotol."},{"issue":"19","key":"10.1016\/j.ijporl.2019.03.021_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1359-6446(05)03552-X","article-title":"Ototoxicity: therapeutic opportunities","volume":"10","author":"Rybak","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"1\u20136","key":"10.1016\/j.ijporl.2019.03.021_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00016488209130876","article-title":"Ototoxicity of the anticancer drug cisplatin. An experimental study","volume":"93","author":"Nakai","year":"1982","journal-title":"Acta Otolaryngol."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib14","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level. (Review)","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MOO.0b013e3282eee452","article-title":"Mechanisms of cisplatin ototoxicity and progress in otoprotection","volume":"15","author":"Rybak","year":"2007","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"issue":"1\u20132","key":"10.1016\/j.ijporl.2019.03.021_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model","volume":"193","author":"Dickey","year":"2004","journal-title":"Hear. Res."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00129492-200411000-00009","article-title":"Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate","volume":"25","author":"Choe","year":"2004","journal-title":"Otol. Neurotol."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1006\/mthe.2001.0334","article-title":"HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage","volume":"3","author":"Chen","year":"2001","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.ijporl.2019.03.021_bib19","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/lary.20515","article-title":"Brain-derived nerve growth factor in the treatment of sensorineural hearing loss","volume":"119","author":"Meen","year":"2009","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.ijporl.2019.03.021_bib20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1177\/153537020623101009","article-title":"Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration","volume":"231","author":"Videhult","year":"2006","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.otohns.2007.05.068","article-title":"The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in Guinea pigs","volume":"137","author":"Daldal","year":"2007","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"7","key":"10.1016\/j.ijporl.2019.03.021_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/MAO.0b013e31818599d5","article-title":"Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections","volume":"29","author":"Hill","year":"2008","journal-title":"Otol. Neurotol."},{"issue":"11","key":"10.1016\/j.ijporl.2019.03.021_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S0022215112001855","article-title":"Effect of intratympanic dexamethasone, memantine and piracetam on cellular apoptosis due to cisplatin ototoxicity","volume":"126","author":"Topdag","year":"2012","journal-title":"J. Laryngol. Otol."},{"issue":"1","key":"10.1016\/j.ijporl.2019.03.021_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anl.2012.05.010","article-title":"Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult Guinea pigs","volume":"40","author":"Shafik","year":"2013","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.ijporl.2019.03.021_bib25","first-page":"63","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicenter, randomised, controlled, open label, phase 3 trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0196-0709(82)80016-1","article-title":"Transport characteristics of the blood--perilymph barrier","volume":"3","author":"Juhn","year":"1982","journal-title":"Am. J. Otolaryngol."},{"issue":"2","key":"10.1016\/j.ijporl.2019.03.021_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.otohns.2005.05.015","article-title":"Intratympanic steroid injection for treatment of idiopathic sudden hearing loss","volume":"133","author":"Slattery","year":"2005","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.ijporl.2019.03.021_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/AUD.0b013e3181c351f2","article-title":"Drug delivery for treatment of inner ear disease: current state of knowledge","volume":"31","author":"McCall","year":"2010","journal-title":"Ear Hear."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","article-title":"Principles of local drug delivery to the inner ear","volume":"14","author":"Salt","year":"2009","journal-title":"Audiol. Neuro. Otol."},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MAO.0b013e318161aaae","article-title":"Dexamethasone concentration gradients along scala tympani after application to the round window membrane","volume":"29","author":"Plontke","year":"2008","journal-title":"Otol. Neurotol."},{"issue":"3 Suppl","key":"10.1016\/j.ijporl.2019.03.021_bib32","first-page":"S1","article-title":"Clinical practice guideline: sudden hearing loss","volume":"146","author":"Stachler","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"9636","key":"10.1016\/j.ijporl.2019.03.021_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","article-title":"Meniere's disease","volume":"372","author":"Sajjadi","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.ijporl.2019.03.021_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1179\/cim.2009.10.Supplement-1.2","article-title":"The multi-channel cochlear implant: past, present and future perspectives","volume":"10","author":"Clark","year":"2009","journal-title":"Cochlear Implants Int."},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/000348947108000306","article-title":"Mucociliary flow in the middle ear","volume":"80","author":"Sade","year":"1971","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000322504","article-title":"Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation","volume":"16","author":"Salt","year":"2011","journal-title":"Audiol. Neuro. Otol."},{"issue":"4","key":"10.1016\/j.ijporl.2019.03.021_bib37","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1177\/014556131109000416","article-title":"Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes","volume":"90","author":"Rutt","year":"2011","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.ijporl.2019.03.021_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5955(89)90013-0","article-title":"Presence of type I and type II\/IB receptors for adrenocorticosteroid hormones in the inner ear","volume":"41","author":"Rarey","year":"1989","journal-title":"Hear. Res."},{"issue":"1","key":"10.1016\/j.ijporl.2019.03.021_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(98)00881-4","article-title":"Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea","volume":"366","author":"Nagura","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijporl.2019.03.021_bib40","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1097\/MLG.0b013e31818173ec","article-title":"Dexamethasone base conserves hearing from electrode trauma-induced hearing loss","volume":"118","author":"Vivero","year":"2008","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.ijporl.2019.03.021_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MAO.0b013e318254501b","article-title":"Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the Guinea pig","volume":"33","author":"Hahn","year":"2012","journal-title":"Otol. Neurotol."},{"issue":"1","key":"10.1016\/j.ijporl.2019.03.021_bib42","first-page":"18","article-title":"A comparison of effects of systemic and intratympanic steroid therapies for sudden sensorineural hearing loss: a meta-analysis","volume":"11","author":"Zhao","year":"2016","journal-title":"J. Otolaryngol."},{"key":"10.1016\/j.ijporl.2019.03.021_bib43","first-page":"3112","article-title":"Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas","volume":"63","author":"Herr","year":"2003","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijporl.2019.03.021_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-199855060-00019","article-title":"Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability","volume":"55","author":"Coukell","year":"1998","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ijporl.2019.03.021_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archopht.1992.01080140111037","article-title":"Intravitreal sustained-release ganciclovir","volume":"110","author":"Smith","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/1080768041223611","article-title":"Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period","volume":"20","author":"Driot","year":"2004","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ijporl.2019.03.021_bib47","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ophtha.2005.03.013","article-title":"Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis","volume":"112","author":"Jaffe","year":"2005","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ijporl.2019.03.021_bib48","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jbm.b.32694","article-title":"A review of polyvinyl alcohol and its uses in cartilage and orthopedic applications","volume":"100","author":"Baker","year":"2012","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0278-6915(02)00258-2","article-title":"Review of the oral toxicity of polyvinyl alcohol (PVA)","volume":"41","author":"DeMerlis","year":"2003","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijporl.2019.03.021_bib50","first-page":"261476","article-title":"Novel starch-PVA polymer for microparticle preparation and optimization using factorial design study","author":"Chattopadhyay","year":"2015","journal-title":"Int. Sch. Res. Notices"},{"issue":"7","key":"10.1016\/j.ijporl.2019.03.021_bib51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/adhm.201400794","article-title":"Magnetically targeted nanocapsules for PAA-cisplatin-conjugated cores in PVA\/SPIO shells via surfactant-free emulsion for reduced nephrotoxicity and enhanced lung cancer therapy","volume":"4","author":"Chiang","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijporl.2019.03.021_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jinorgbio.2014.02.004","article-title":"A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin, and polyvinyl alcohol","volume":"134","author":"Oun","year":"2014","journal-title":"J. Inorg. Biochem."},{"issue":"3","key":"10.1016\/j.ijporl.2019.03.021_bib53","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12221-017-6958-5","article-title":"pH sensitive and controlled release system based on cellulose nanofibers-poly vinyl alcohol hydrogels for cisplatin delivery","volume":"18","author":"Azhar","year":"2017","journal-title":"Fibers Polym."},{"key":"10.1016\/j.ijporl.2019.03.021_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5152\/dir.2014.13462","article-title":"The effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol","volume":"20","author":"Ko\u00e7yi\u011fit","year":"2014","journal-title":"Diagn. Interv. Radiol."},{"key":"10.1016\/j.ijporl.2019.03.021_bib55","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4236\/jbise.2013.65074","article-title":"Controlled release of cisplatin and cancer cell apoptosis with cisplatin encapsulated poly(lactic-co-glycolic acid) nanoparticles","volume":"6","author":"Jayasuriya","year":"2013","journal-title":"J. Biomed. Sci. Eng."}],"container-title":["International Journal of Pediatric Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165587619301429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165587619301429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:51:14Z","timestamp":1759049474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165587619301429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":55,"alternative-id":["S0165587619301429"],"URL":"https:\/\/doi.org\/10.1016\/j.ijporl.2019.03.021","relation":{},"ISSN":["0165-5876"],"issn-type":[{"value":"0165-5876","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pediatric Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijporl.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}